Therefore, the principle issue behind a therapeutic intervention based on FoxP3+CD25+CD4+ Treg modulation is identifying the precise roles of FoxP3+CD25+CD4+ Tregs at specific stages of stroke. This evidence concerns the gene CD4 and stroke disorder.